Literature DB >> 10208453

Mapping susceptibility loci in attention deficit hyperactivity disorder: preferential transmission of parental alleles at DAT1, DBH and DRD5 to affected children.

G Daly1, Z Hawi, M Fitzgerald, M Gill.   

Abstract

Attention deficit hyperactivity disorder (ADHD) is a common disorder of childhood characterized by inattention, excessive motor activity, impulsivity, and distractibility. It is associated with serious disability in children, adolescents and adults. The etiology of the disorder is unknown, but it has a strong genetic component. Pharmacological and biochemical studies have suggested that dopaminergic and noradrenergic systems are involved. Using a sample of affected children and their parents we have found preferential transmission of alleles at polymorphisms at the dopamine transporter (DAT1), RR=1.2 (1.05-1.37), P=0.006, re-confirming and extending our previous findings for DAT1 (new sample one-tailed P=0.039); dopamine-beta-hydroxylase (DBH), RR=1.31 (1.09-1.56), P=0.0027; and the dopamine D5 receptor (DRD5), RR=1.67 (1.29-2.15), P=0.00005. Transmission of the 'associated' alleles at DAT1 and DBH is stronger in familial cases, RR(DAT1)=1.29 (1.04-1.59), RR(DBH)=1.49 (1.10-2.00), but for DRD5, transmission is stronger in non-familial cases, RR=1.59 (1.05-2.42). TDT analysis of complete trios supports the HHRR analysis, with P<0.05, for DAT1 P<0.005 and DBH and P<0.01 for DRD5. Attributable fractions for DAT1, DBH and DRD5 are calculated at 0.08, 0.12 and 0.20 respectively.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10208453     DOI: 10.1038/sj.mp.4000510

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  73 in total

1.  Family-based tests of association and linkage that use unaffected sibs, covariates, and interactions.

Authors:  K L Lunetta; S V Faraone; J Biederman; N M Laird
Journal:  Am J Hum Genet       Date:  2000-02       Impact factor: 11.025

Review 2.  Experimental analyses of gene-brain-behavior relations: some notes on their application.

Authors:  C H Kennedy; M Caruso; T Thompson
Journal:  J Appl Behav Anal       Date:  2001

Review 3.  The use of &#x03B1;-2A adrenergic agonists for the treatment of attention-deficit/hyperactivity disorder.

Authors:  Amy F T Arnsten
Journal:  Expert Rev Neurother       Date:  2010-10       Impact factor: 4.618

Review 4.  Normal genetic variation, cognition, and aging.

Authors:  P M Greenwood; Raja Parasuraman
Journal:  Behav Cogn Neurosci Rev       Date:  2003-12

5.  Effect of dopamine transporter genotype on intrinsic functional connectivity depends on cognitive state.

Authors:  Evan M Gordon; Melanie Stollstorff; Joseph M Devaney; Stephanie Bean; Chandan J Vaidya
Journal:  Cereb Cortex       Date:  2011-11-02       Impact factor: 5.357

6.  The DBH -1021 C/T polymorphism is not associated with alcoholism but possibly with patients' exposure to life events.

Authors:  M T M V Freire; M H Hutz; C H D Bau
Journal:  J Neural Transm (Vienna)       Date:  2005-09       Impact factor: 3.575

7.  Contributions of the DAT1 and DRD2 genes to serious and violent delinquency among adolescents and young adults.

Authors:  Guang Guo; Michael E Roettger; Jean C Shih
Journal:  Hum Genet       Date:  2006-10-31       Impact factor: 4.132

Review 8.  Human genetics of plasma dopamine beta-hydroxylase activity: applications to research in psychiatry and neurology.

Authors:  J F Cubells; C P Zabetian
Journal:  Psychopharmacology (Berl)       Date:  2004-04-16       Impact factor: 4.530

9.  Association of dopamine transporter gene variants with childhood ADHD features in bipolar disorder.

Authors:  Tiffany A Greenwood; Eun-Jeong Joo; Tatyana Shekhtman; A Dessa Sadovnick; Ronald A Remick; Paul E Keck; Susan L McElroy; John R Kelsoe
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2012-12-19       Impact factor: 3.568

10.  Molecular genetic contribution to the developmental course of attention-deficit hyperactivity disorder.

Authors:  Kate Langley; Tom A Fowler; Deborah L Grady; Robert K Moyzis; Peter A Holmans; Marianne B M van den Bree; Michael J Owen; Michael C O'Donovan; Anita Thapar
Journal:  Eur Child Adolesc Psychiatry       Date:  2008-06-18       Impact factor: 4.785

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.